Goldman Sachs Upgrades Charles River Labs (CRL) to Neutral
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $295.19 +1.28%
Rating Summary:
23 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
23 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Goldman Sachs upgraded Charles River Labs (NYSE: CRL) from Sell to Neutral with a price target of $77.00 (from $75.00).
For an analyst ratings summary and ratings history on Charles River Labs click here. For more ratings news on Charles River Labs click here.
Shares of Charles River Labs closed at $76.50 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Charles River and Medigen to use NGS for enterovirus vaccine work
- Agilent (A) PT Raised to $150 at Jefferies
- Sinclair Broadcasting (SBGI) PT Raised to $15 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
